Sfoglia per RIVISTA
TRANSLATIONAL LUNG CANCER RESEARCH
Collezione AOU San Luigi di Orbassano

  

Items : 23

Treatment response and safety of immunotherapy for advanced non-small cell lung cancer with comorbid chronic obstructive pulmonary disease: a retrospective cohort study. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Nov;11(11):2306-2317. doi: 10.21037/tlcr-22-667.

2022
AOU San Luigi di Orbassano

Zhang K; Zhou C; Gao J; Yu P; Lin X; Xie X; Liu M; Zhang J; Xie Z; Cui F; Li S; Passiglia F; Stella GM; Qin Y;

Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review. in Translational lung cancer research / Transl Lung Cancer Res. 2022 May;11(5):935-949. doi: 10.21037/tlcr-22-1.

2022
AOU San Luigi di Orbassano

Passiglia F; Bironzo P; Bertaglia V; Listì A; Garbo E; Scagliotti GV;

2022
AOU San Luigi di Orbassano

Wen S; Du X; Chen Y; Xia J; Wang R; Zhu M; Peng W; Spitaleri G; Hofman P; Bironzo P; Wang X; Shen B;

Rate and risk factors of recurrent immune checkpoint inhibitor-related pneumonitis in patients with lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Mar;11(3):381-392. doi: 10.21037/tlcr-22-168.

2022
AOU San Luigi di Orbassano

Tao H; Li F; Wu D; Ji S; Liu Q; Wang L; Liu B; Facchinetti F; Leong TL; Passiglia F; Hu Y;

Expert consensus on perioperative treatment for non-small cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Jul;11(7):1247-1267. doi: 10.21037/tlcr-22-527.

2022
AOU San Luigi di Orbassano

Duan J; Tan F; Bi N; Chen C; Chen KN; Cheng Y; Chu Q; Ge D; Hu J; Huang Y; Jiang T; Long H; Lu Y; Shi M; Wang J; Wang Q; Yang F; Yang N; Yao Y; Ying J; Zhou C; Zhou Q; Zhou Q; Bongiolatti S; Brunelli A; Fiorelli A; Gobbini E; Gridelli C; John T; et alii...

Smoking burden, MPOWER, future tobacco control and real-world challenges in China: reflections on the WHO report on the global tobacco epidemic 2021. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Jan;11(1):117-121. doi: 10.21037/tlcr-22-27.

2022
AOU San Luigi di Orbassano

Zhang K; Tartarone A; Pérez-Ríos M; Novello S; Mariniello A; Roviello G; Zhang J;

Expert consensus on resection of chest wall tumors and chest wall reconstruction. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Nov;10(11):4057-4083. doi: 10.21037/tlcr-21-935.

2021
AOU San Luigi di Orbassano

Wang L; Yan X; Zhao J; Chen C; Chen C; Chen J; Chen KN; Cao T; Chen MW; Duan H; Fan J; Fu J; Gao S; Guo H; Guo S; Guo W; Han Y; Jiang GN; Jiang H; Jiao WJ; Kang M; Leng X; Li HC; Li J; Li J; Li SM; Li S; Li Z; Li Z; et alii...

Exploring the immune-checkpoint inhibitors' efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jun;10(6):2876-2889. doi: 10.21037/tlcr-20-635.

2021
AOU San Luigi di Orbassano

Passiglia F; Cetoretta V; De Filippis M; Napoli V; Novello S;

Local for advanced, is this a paradox? in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jul;10(7):3324-3328. doi: 10.21037/tlcr-20-771.

2021
AOU San Luigi di Orbassano

Bungaro M; Paratore C; Bironzo P; Novello S;

2021
AOU San Luigi di Orbassano

Passiglia F; Galvano A; Gristina V; Barraco N; Castiglia M; Perez A; La Mantia M; Russo A; Bazan V;

Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jul;10(7):3191-3202. doi: 10.21037/tlcr-21-455.

2021
AOU San Luigi di Orbassano

Zhang X; Tian D; Chen Y; Chen C; He LN; Zhou Y; Li H; Lin Z; Chen T; Wang Y; Russo A; Nadal E; Passiglia F; Soo RA; Watanabe S; Moran T; Oh IJ; Fu S; Hong S; Zhang L;

Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: are we actually ready? in Translational lung cancer research / Transl Lung Cancer Res. 2020 Oct;9(5):1724-1727. doi: 10.21037/tlcr-20-545.

2020
AOU San Luigi di Orbassano

Tabbò F; Reale ML; Novello S;

Prognostic factors of lung cancer in lymphoma survivors (the LuCiLyS study). in Translational lung cancer research / Transl Lung Cancer Res. 2020 Feb;9(1):90-102. doi: 10.21037/tlcr.2019.12.28.

2020
AOU San Luigi di Orbassano

Fiorelli A; D'Andrilli A; Carlucci A; Vicidomini G; Loizzi D; Ardò NP; Marasco RD; Ventura L; Ampollini L; Carbognani P; Bocchialini G; Lococo F; Paci M; Di Stefano TS; Ardissone F; Gagliasso M; Mendogni P; Rosso L; Mazzucco A; Vanni C; Marinucci BT; Potenza R; Matricardi A; Ragusa M; Tassi V; Anile M; Poggi C; Serra N; Sica A; et alii...

Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going? in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2518-2520. doi: 10.21037/tlcr-2019-cnsclc-14.

2020
AOU San Luigi di Orbassano

Passiglia F; Novello S;

Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won. in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2545-2556. doi: 10.21037/tlcr-20-372.

2020
AOU San Luigi di Orbassano

Tabbò F; Reale ML; Bironzo P; Scagliotti GV;

Future perspectives from lung cancer pre-clinical models: new treatments are coming? in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2629-2644. doi: 10.21037/tlcr-20-189.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Righi L; Bironzo P; Tabbò F; Morotti A; Picca F; Morena D; Bersani F; Taulli R;

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?-a literature review. in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2674-2685. doi: 10.21037/tlcr-20-710.

2020
AOU San Luigi di Orbassano

Leone G; Passiglia F; Bironzo P; Bertaglia V; Novello S;

First-line immune-chemotherapy combination: the right strategy to fight squamous non-small cell lung cancer? in Translational lung cancer research / Transl Lung Cancer Res. 2019 Aug;8(4):546-549. doi: 10.21037/tlcr.2019.04.05.

2019
AOU San Luigi di Orbassano

Passiglia F; Bironzo P; Scagliotti GV;

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors. in Translational lung cancer research / Transl Lung Cancer Res. 2016 Jun;5(3):301-21. doi: 10.21037/tlcr.2016.06.10.

2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Rossi G; Bria E; Graziano P; Di Maio M; Tiseo M; Facchinetti F;

Raising the bar for enthusiasm when looking at results of randomized phase II trials-the case of sunitinib in small-cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2016 Feb;5(1):89-91. doi: 10.3978/j.issn.2218-6751.2015.07.18.

2016
AOU San Luigi di Orbassano

Di Maio M; Bironzo P; Scagliotti GV;

Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2016 Dec;5(6):610-627. doi: 10.21037/tlcr.2016.09.03.

2016
AOU San Luigi di Orbassano

Buttigliero C; Bertaglia V; Novello S;

2014
AOU San Luigi di Orbassano

Novello S; Capelletto E; Cortinovis D; Tiseo M; Galetta D; Valmadre G; Casartelli C; Rapetti SG; Rossi A;

MET inhibition in lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2013 Feb;2(1):23-39. doi: 10.3978/j.issn.2218-6751.2012.12.04.

2013
AOU San Luigi di Orbassano

Menis J; Giaj Levra M; Novello S;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte